Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer - implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils.

Autor: Karlsson V; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.; Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Stål E; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden., Stoopendahl E; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden., Ivarsson A; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden., Leffler H; Department of Laboratory Medicine, Lund University, Lund, Sweden., Lycke M; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Sundqvist M; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Sundfeldt K; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Christenson K; Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Bernson E; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Dec 20; Vol. 15, pp. 1506236. Date of Electronic Publication: 2024 Dec 20 (Print Publication: 2024).

Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium

Autor: Kenis, C., Decoster, L., Flamaing, J., Debruyne, P.R., De Groof, I., Focan, C., Cornélis, F., Verschaeve, V., Bachmann, C., Bron, D., Luce, S., Debugne, G., Van den Bulck, H., Goeminne, J.-C., Schrijvers, D., Geboers, K., Petit, B., Langenaeken, C., Van Rijswijk, R., Specenier, P., Jerusalem, G., Praet, J.-P., Vandenborre, K., Lobelle, J.-P., Lycke, M., Milisen, K., Wildiers, H. ^*

Publikováno v: In Annals of Oncology September 2018 29(9):1987-1994

Transcatheter aortic valve replacement: impact of pre-procedural FEops HEARTguide assessment on device size selection in borderline annulus size cases.

Autor: Halim, J., Brouwer, J., Lycke, M., Swaans, M. J., Van der Heyden, J.

Publikováno v: Netherlands Heart Journal; Dec2021, Vol. 29 Issue 12, p654-661, 8p

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.

Autor: Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada., Kang EY; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada., Weir A; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Rambau PF; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.; Pathology Department, Catholic University of Health and Allied Sciences-Bugando, Mwanza, Tanzania., Lee CH; Department of Pathology and Laboratory Medicine, University of Alberta, Edmonton, AB, Canada., Nelson GS; Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Ghatage P; Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Meagher NS; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia., Riggan MJ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA., Alsop J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Anglesio MS; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.; British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada., Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany., Bisinotto C; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Boisen M; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Boros J; Centre for Cancer Research, The Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; Discipline of Obstetrics and Gynaecology, The University of Sydney, Sydney, New South Wales, Australia., Brand AH; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; Discipline of Obstetrics and Gynaecology, The University of Sydney, Sydney, New South Wales, Australia., Brooks-Wilson A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Carney ME; Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA., Coulson P; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Courtney-Brooks M; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Cushing-Haugen KL; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Cybulski C; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Deen S; Department of Histopathology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, UK., El-Bahrawy MA; Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Hospital, London, UK., Elishaev E; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Erber R; Institute of Pathology, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany., Fereday S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Fischer A; Institute of Pathology and Neuropathology, Tuebingen University Hospital, Tuebingen, Germany., Gayther SA; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Barquin-Garcia A; HM Sanchinarro Centro Integral Oncológico Clara Campal, University Hospital, Madrid, Spain., Gentry-Maharaj A; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK., Gilks CB; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Gronwald H; Department of Propaedeutics, Physical Diagnostics and Dental Physiotherapy, Pomeranian Medical University, Szczecin, Poland., Grube M; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany., Harnett PR; Discipline of Obstetrics and Gynaecology, The University of Sydney, Sydney, New South Wales, Australia.; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia., Harris HR; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA., Hartkopf AD; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.; Department of Gynecology and Obstetrics, University Hospital of Ulm, Ulm, Germany., Hartmann A; Institute of Pathology, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany., Hein A; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany., Hendley J; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hernandez BY; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA., Huang Y; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Jakubowska A; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland., Jimenez-Linan M; Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK., Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Kennedy CJ; Centre for Cancer Research, The Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; Discipline of Obstetrics and Gynaecology, The University of Sydney, Sydney, New South Wales, Australia., Kluz T; Department of Gynecology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszów, Poland., Koziak JM; Alberta Health Services-Cancer Care, Calgary, AB, Canada., Lesnock J; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Lester J; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA., Lubiński J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Longacre TA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Lycke M; Department of Obstetrics and Gynecology, Institute of Clinical Science, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden., Mateoiu C; Department of Pathology, University of Gothenburg, Gothenburg, Sweden., McCauley BM; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA., McGuire V; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA., Ney B; Institute of Pathology and Neuropathology, Tuebingen University Hospital, Tuebingen, Germany., Olawaiye A; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Orsulic S; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA., Osorio A; Genetics Service, Fundación Jiménez Díaz, Madrid, Spain.; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Paz-Ares L; H12O-CNIO Lung Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Ramón Y Cajal T; Medical Oncology Service, Hospital Sant Pau, Barcelona, Spain., Rothstein JH; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ruebner M; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany., Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Sharma R; Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Sydney, New South Wales, Australia., Sherman ME; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA., Shvetsov YB; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA., Singh N; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Steed H; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alberta, Edmonton, AB, Canada.; Section of Gynecologic Oncology Surgery, North Zone, Alberta Health Services, Edmonton, AB, Canada., Storr SJ; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, UK., Talhouk A; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.; British Columbia's Gynecological Cancer Research Team (OVCARE), University of British Columbia, BC Cancer, and Vancouver General Hospital, Vancouver, BC, Canada., Traficante N; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Wang C; Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, USA., Whittemore AS; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA., Widschwendter M; EUTOPS Institute, University of Innsbruck, Innsbruck, Austria., Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA., Winham SJ; Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, USA., Benitez J; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Berchuck A; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA., Bowtell DD; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Candido Dos Reis FJ; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Campbell I; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Cook LS; Epidemiology, School of Public Health, University of Colorado, Aurora, CO, USA.; Community Health Sciences, University of Calgary, Calgary, AB, Canada., DeFazio A; The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Centre for Cancer Research, The Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.; Discipline of Obstetrics and Gynaecology, The University of Sydney, Sydney, New South Wales, Australia., Doherty JA; Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA., Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany., Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Research, Cancer Registry of Norway, Oslo, Norway., García MJ; Computational Oncology Group, Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Goodman MT; Cancer Prevention and Control Program, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Goode EL; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA., Gronwald J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Huntsman DG; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada., Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA., Kelemen LE; Division of Acute Disease Epidemiology, South Carolina Department of Health & Environmental Control, Columbia, SC, USA., Kommoss S; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany., Le ND; Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada., Martin SG; Nottingham Breast Cancer Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, UK., Menon U; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK., Modugno F; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.; Women's Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, PA, USA., Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Department of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, CA, USA.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Schildkraut JM; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Sieh W; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Staebler A; Institute of Pathology and Neuropathology, Tuebingen University Hospital, Tuebingen, Germany., Sundfeldt K; Department of Obstetrics and Gynecology, Institute of Clinical Science, Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden., Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK., Ramus SJ; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

Publikováno v: The journal of pathology. Clinical research [J Pathol Clin Res] 2023 May; Vol. 9 (3), pp. 208-222. Date of Electronic Publication: 2023 Mar 22.

Very High-Power Ablation for Contiguous Pulmonary Vein Isolation: Results From the Randomized POWER PLUS Trial.

Autor: O'Neill L; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium. Electronic address: louisa.oneill@azsintjan.be., El Haddad M; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium., Berte B; Luzerner Kantonsspital, Luzern, Switzerland., Kobza R; Luzerner Kantonsspital, Luzern, Switzerland., Hilfiker G; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium; Luzerner Kantonsspital, Luzern, Switzerland., Scherr D; Division of Cardiology, Department of Medicine, Medical University of Graz, Graz, Austria., Manninger M; Division of Cardiology, Department of Medicine, Medical University of Graz, Graz, Austria., Wijnmaalen AP; Department of Cardiology, Willem Einthoven Center for Cardiac Arrhythmia Research and Management, Leiden University Medical Center, Leiden, the Netherlands., Trines SA; Department of Cardiology, Willem Einthoven Center for Cardiac Arrhythmia Research and Management, Leiden University Medical Center, Leiden, the Netherlands., Wielandts JY; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium., Gillis K; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium., Lycke M; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium., De Becker B; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium., Tavernier R; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium., Le Polain De Waroux JB; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium., Knecht S; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium., Duytschaever M; Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium.

Publikováno v: JACC. Clinical electrophysiology [JACC Clin Electrophysiol] 2023 Apr; Vol. 9 (4), pp. 511-522. Date of Electronic Publication: 2023 Jan 18.